BATTISTUTTA, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 5.866
EU - Europa 619
AS - Asia 516
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 7.007
Nazione #
US - Stati Uniti d'America 5.863
CN - Cina 298
SG - Singapore 164
IT - Italia 149
FI - Finlandia 147
DE - Germania 104
UA - Ucraina 53
GB - Regno Unito 51
SE - Svezia 48
FR - Francia 43
VN - Vietnam 30
IE - Irlanda 12
IN - India 10
HK - Hong Kong 7
RU - Federazione Russa 5
CA - Canada 3
KR - Corea 3
NL - Olanda 3
BD - Bangladesh 2
EU - Europa 2
JP - Giappone 2
AR - Argentina 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CL - Cile 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 7.007
Città #
Fairfield 987
Woodbridge 688
Ann Arbor 551
Houston 502
Chandler 450
Ashburn 391
Seattle 351
Wilmington 318
Cambridge 305
Jacksonville 295
Princeton 134
Singapore 121
San Diego 92
Beijing 79
Helsinki 76
Roxbury 70
Padova 66
Des Moines 57
Nanjing 52
Medford 36
Boardman 35
Dong Ket 30
Shenyang 23
Nanchang 20
Santa Clara 20
Hebei 16
Falls Church 15
Norwalk 13
Ogden 13
Changsha 12
Chicago 12
Dublin 12
Guangzhou 11
London 11
Jiaxing 10
Jinan 9
Hefei 7
Los Angeles 7
Shanghai 7
Tianjin 7
Washington 7
Redwood City 6
Rome 6
Indiana 5
Kilburn 5
Ningbo 5
Cesano Maderno 4
Chiswick 4
Hong Kong 4
Kharkiv 4
Legnaro 4
New York 4
Taizhou 4
Acton 3
Borås 3
Cittadella 3
Columbus 3
Detroit 3
Frankfurt am Main 3
Kunming 3
Nürnberg 3
Alghero 2
Dallas 2
Groningen 2
Hangzhou 2
Hounslow 2
Liverpool 2
Melzo 2
Munich 2
Napa 2
Palermo 2
Prescot 2
Pune 2
San Francisco 2
Tokyo 2
Treviso 2
Trieste 2
Verona 2
Zhengzhou 2
Arezzo 1
Augusta 1
Belluno 1
Bengaluru 1
Bethesda 1
Bologna 1
Bozzolo 1
Budapest 1
Burton-on-Trent 1
Chieti 1
Cordoba 1
Costa Mesa 1
Dhaka 1
Dongjak-gu 1
Durham 1
Edmond 1
Falkenstein 1
Florence 1
Frederick 1
Grado 1
Homburg 1
Totale 6.054
Nome #
ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update 184
Crystal Structure of Amine Oxidase from Bovine Serum 176
Structure of the Cytosolic Portion of the Motor Protein Prestin and Functional Role of the STAS Domain in SLC26/SulP Anion Transporters 176
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight. 164
Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA) 158
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2 152
A structural insight into CK2 inhibition 141
Structure of the neutrophil activating protein from helicobacter pylori 132
Axonal Odorant Receptors Mediate Axon Targeting 126
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype 122
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential 120
The Replacement of ATP by the Competitive Inhibitor Emodin Induces Conformational Modifications in the Catalytic Site of Protein Kinase CK2 118
Crystallization and preliminary X-ray data of amine oxidase from bovine serum 117
Structure at 1.44 A resolution of a N-terminally truncated form of rat serum complement C3d,g fragment 113
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2 112
Crystal structure of CagZ, a protein from the Helicobacter pylori pathogenicity island that encodes for a type IV secretion system 111
Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin 108
Crystal structure and refolding properties of the mutant F99S/M153T/V163A of the Green Fluorescent Protein 107
Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain 106
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 106
Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole 104
Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole 104
Conformation of Retro-bombolitin-i In Aqueous-solution Containing Surfactant Micelles 103
Probing an Allosteric Pocket of CDK2 with Small Molecules 103
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A 101
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 101
TAP score: torsion angle propensity normalization applied to local protein structure evaluation 100
pH-Dependent Conformational Changes and Topology of Herpesvirus Translocating Peptide in a Membrane-Mimetic Enviroment. 98
Inhibitors of protein kinase CK2: structural aspects 97
Toward the rational design of protein kinase casein kinase-2 inhibitors 97
Structure of two iron-binding proteins from Bacillus anthracis 93
Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2. 91
Structural Determinants of Protein Kinase CK2 Regulation by Autoinhibitory Polymerization 91
Circular dichroism and 1H-NMR studies on bombolitin-related peptides in aqueous solution containing SDS-micelles 90
Crystal structure of the PsbQ protein of photosystem II from higher plants 89
Conformational Properties of the Amphipathic Lytic Polypeptide Bombolitin-ii - A Circular-dichroism, Nmr and Computer-simulation Study 88
Features and potentials of ATP-site directed CK2 inhibitors 85
Crystal structure of alkyl hydroperoxide-reductase (AhpC) from Helicobacter pylori 85
Molecular architecture and the structural basis for anion interaction in prestin and SLC26 transporters 83
The crystal structure of CagS from the Helicobacter pylori pathogenicity island. 82
Structure and single crystal spectroscopy of Green Fluorescent Proteins 80
The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules 79
Conformational studies on bombolitin III-related peptides in aqueous solution containing SDS 77
Expression, purification and characterisation of the C-terminal STAS domain of the SLC26 anion transporter prestin 77
Does CK2 start chromatin condensation in mitotic phase? 76
A Structural Model for Prestin and Related SLC26 Anion Transporters 75
A novel class of selective CK2 inhibitors targeting its open hinge conformation 75
Susceptibility of the prion protein to enzymatic phosphorylation 73
Conformational and Binding-studies On Peptides Related To Domain-i and Domain-iii of Calmodulin 71
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer 71
Structural basis of CK2 regulation by autoinhibitory oligomerization 70
Structural features of protein kinase CK2. 69
Active Form of the Protein Kinase CK2 alpha(2)beta(2) holoenzyme Is a Strong Complex with Symmetric Architecture 69
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility 68
Crystal structure of the B subunit of Escherichia coli heat-labile enterotoxin carrying peptides with anti-herpes simplex virus type 1 activity. 67
Coumarin as attractive casein kinase 2(CK2) inhibitor scaffold: an integrated approach to elucidate the putative binding motif and explain structure-activity relationship. 67
Insight into GFPmut2 pH Dependence by Single Crystal Microspectrophotometry and X-ray Crystallography 67
Structure-activity relationship of protein kinase CK2 inhibitors with different scaffolds 65
Distinctive binding and structural properties of piscine transthyretin 64
The STAS domain of mammalian SLC26A5 prestin harbours an anion-binding site 63
IDENTIFICATION OF NEW SARS-COV-2 MAIN PROTEASE INHIBITORS BY AN INTEGRATED IN-SILICO AND IN-VITRO STRATEGY 61
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot - Models for collagen catabolism by matrix-metalloproteases 58
A comparative analysis of the properties of Dpl and PrPC. 58
The crystal structure of the complex of Zea mays alpha subunit with a fragment of human beta subunit provides the clue to the architecture of protein kinase CK2 holoenzyme. 57
Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight 57
Structural bases of protein kinase CK2 function and inhibition. 54
Crystal structure of antigen TpF1 from Treponema pallidum. 53
Generation of mutants of CK2 alpha which are dependent on the beta-subunit for catalytic activity. 50
Molecular organisation of the ice nucleation protein InaV from Pseudomonas syringae 49
Structural-properties of Recombinant Domain Iii-3 of Perlecan Containing A Globular Domain Inserted Into An Epidermal-growth-factor-like Motif Rid C-4254-2008 49
A new inactive conformation of SARS-CoV-2 main protease 49
Towards the understanding of molecular aspects of Helicobacter pylori cag-PAI 46
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation 44
Synthesis of multiple-cystine-peptides. 42
Structural and functional determinants of protein kinase CK2 alpha: facts and open questions 41
Characterization of the oligomeric states of the CK2 alpha2beta2 holoenzyme in solution 41
Calmodulin binds to the STAS domain of SLC26A5 prestin with a calcium-dependent, one-lobe, binding mode 41
Synthesis of a heterotrimeric triple helical „mini-collagen“ with a C-terminal disulfide knot for induction of the correct register. 39
Functional and structural characterization of ovine ornithine transcarbamoylase 35
The Natural Human-igg Anti-f(ab')(2) Antibody Recognizes A Conformational Igg1 Hinge Epitope 32
Structural bases of protein kinase CK2 inhibition 30
Comparative molecular dynamics investigation of the electromotile hearing protein prestin 30
Structural basis for selective inhibition of protein kinase CK2 by ATP site-directed ligands 28
Structure at 1.44 angstrom resolution of rat serum complement C3D 28
One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse 18
Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate 15
Totale 7.062
Categoria #
all - tutte 26.117
article - articoli 23.651
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.027
Totale 50.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.423 0 0 27 292 152 116 136 186 200 147 102 65
2020/2021871 47 68 45 40 34 74 23 92 134 119 120 75
2021/20221.251 28 125 233 68 50 56 54 156 53 32 158 238
2022/2023921 181 109 10 117 135 126 4 53 117 9 44 16
2023/2024474 24 71 57 39 59 37 22 24 21 17 74 29
2024/2025212 8 122 82 0 0 0 0 0 0 0 0 0
Totale 7.062